3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Multiple Myeloma
60
Lymphoma
56
Leukemia, Myeloid, Acute
51
Leukemia
50
Lymphoma, Non-Hodgkin
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Hodgkin Disease
36
Myelodysplastic Syndromes
28
Lymphoma, Large B-Cell, Diffuse
27
Breast Neoplasms
24
Lymphoma, Mantle-Cell
23
Neuroblastoma
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Burkitt Lymphoma
17
Lymphoma, Follicular
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Central Nervous System Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Sarcoma
11
Neoplasms, Plasma Cell
11
Brain Neoplasms
11
Recurrence
10
Lymphoma, B-Cell, Marginal Zone
10
Neoplasms
9
Hematologic Neoplasms
9
Congenital Abnormalities
9
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Biphenotypic, Acute
8
Graft vs Host Disease
8
Interventions
Carboplatin
341
Paclitaxel
262
Cisplatin
233
Pemetrexed
226
Docetaxel
206
Erlotinib Hydrochloride
193
Gemcitabine
178
pembrolizumab
137
Bevacizumab
121
Radiotherapy
118
Nivolumab
84
Gefitinib
73
Vinorelbine
64
Cetuximab
58
atezolizumab
47
Afatinib
46
durvalumab
44
osimertinib
41
Radiosurgery
35
Ipilimumab
34
Drug Therapy
32
Taxes
30
Albumin-Bound Paclitaxel
29
130-nm albumin-bound paclitaxel
29
Surgical Procedures, Operative
28
Etoposide
25
Irinotecan
24
Sorafenib
21
Cyclophosphamide
20
Radiation
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Non-Small-Cell Lung
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT01840579
2021-06-22
MK-3475-011
Merck Sharp & Dohme LLC
Phase 1
Completed
57 enrolled
60 charts